Tilsotolimod
| Catalog Number | Pack Size | List Price* | Quantity | |
|---|---|---|---|---|
| HY-150212-1MG | 1 mg | 775,00 | Add | |
| HY-150212-5MG | 5 mg | 2'280,00 | Add | |
| HY-150212-10MG | 10 mg | 3'637,00 | Add |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.
IMO-2125
Tilsotolimod (IMO-2125) is a TLR9 agonist. Tilsotolimod activates the TLR9 signaling pathway, triggers downstream pro-inflammatory and immunostimulatory pathways, enhances the uptake and killing of cancer cells, and induces adaptive immune responses. Tilsotolimod is applicable to research related to melanoma and colorectal cancer[1].
| Category | RNAi |
| Supplier | MedChem Express |
| Regulatory Status | RUO |
| Research Field | Cancer;Inflammation/Immunology |
| Format | Solubility: 10 mM in H2O |
| Grade | Clinical information: No Development Reported |
| Purity | 99.46% |
| Molecular Formula | C223H284N74O115P22S22 |
| Molecular Weight | 7228 |
| CAS-Number | 1948266-37-2 |
| Storage Conditions | -20°C (Powder, sealed storage, away from moisture) |
| Tech. Data Sheet | View datasheet |
| Link To Supplier | http://www.medchemexpress.com |
| Shipping Details | Blue Ice |
| Material Safety Data Sheet | Download PDF |
